Latest Breaking News On - Sponsored level - Page 1 : comparemela.com

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13 11 23

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine | 13 11 23
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalUnited statesIpsen euronextIoana piscociuJean christophe marcouxChristelle huguetStephanie boyerAnna gibbinsMo christieChristopher bowlusAmy wolfNicolas boglerGlobal head of franchise communicationsUniversity of california davisHead of patient services

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition

France generalUnited kingdomUnited statesJennifer mooreAmy wolfStewart campbellMedison pharmaBinita kamathDara willisIpsen euronextIntrahepatic cholestasisIoana piscociuNicolas boglerGastroenterol hepatolWalter perezInbal chen

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine

GENFIT: Results from Ipsen s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalUnited statesAmy wolfIpsen euronextAnna gibbinsStephanie boyerIoana piscociuJean christophe marcouxChristopher bowlusChristelle huguetMo christieNicolas boglerUniversity of california davisGlobal head of franchise communicationsUncertainties of the company

Investegate | Company Announcement

Investegate | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesFrance generalUnited kingdomIpsen euronextIoana piscociuStephanie boyerAmy wolfAnna gibbinsNicolas boglerGlobal head of franchise communicationsHead of corporate brand strategy communicationsExchange commissionUncertainties of the companyNew england journalAmerican associationLiver disease

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomUnited statesStewart campbellInbal chenAmy wolfIpsen euronextNicolas boglerBinita kamathIntrahepatic cholestasisMedison pharmaWalter perezJennifer mooreDara willisGastroenterol hepatolIoana piscociu